Press Releases

Press Releases

Johnson & Johnson today announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance (AMR), an industry-wide call to action announced at the World Economic Forum in Davos, Switzerland. The declaration outlines for the first time how industry and governments can work…

Press Releases

Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds. ACCF is a novel investment vehicle focused on…

Press Releases

Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2015 on Wednesday, February 3, 2016 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and…

Wednesday, Jan 20, 2016
Press Releases

Bioclinica®, Inc., a specialty clinical trials services and technology provider, announced today that it has acquired Clinverse, Inc. The acquisition expands Bioclinica's offerings into the growing market of automated financial management technology solutions for global clinical trials. Clinverse is the latest investment that Bioclinica has completed to build the company…

Press Releases

Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Felbamate Tablets USP, 400 mg and 600 mg, which is the generic version of Meda Pharms' Felbatol® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this…

Press Releases

PAREXEL International Corporation, a leading global biopharmaceutical services organization, today announced that the Company has entered into a definitive agreement to acquire all outstanding equity securities of Health Advances, LLC (“Health Advances”), an independent life sciences strategy consulting firm. Health Advances combines clinical, scientific and business expertise to provide strategic…

Press Releases

Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has helped Medicines360 gain FDA approval for their hormonal intrauterine contraceptive device. "2015 was a very successful year: our (Medicines360) first NDA was approved and Camargo played a crucial role in…

Press Releases

This upcoming webinar hosted by Oxford Global will provide an insight on the Advances In Inhaled Insulin Research on Wednesday 17th February 2016 | 3 pm GmT. Register for this free webinar here: http://bit.ly/1ZkhBAy About the Webinar: Inhalable insulin research represents a very exciting area of the inhalation drug delivery…

Press Releases

This upcoming webinar hosted by Oxford Global will provide an insight on the Advances In Small Molecule Drugs Formulation Research on Thursday 11th February 2016 | 2 pm GmT. Register for this free webinar here: http://bit.ly/1HQsBkP About the Webinar: The formulation market represents a complex part of the industry that…

Press Releases

On the 17th of May, professionals from cold & supply chain, logistics, distribution, warehousing, quality assurance and validation, sales and operations planning, transport, packaging and shipping companies will gather in Amsterdam, the Netherlands, for the 6th Cold Chain & Product Handling: Temperature Controlled Logistics forum. For three days, they will…